Primo Chemicals profit and loss

Latest FY26
Revenue
₹562cr+1.1% on FY25
EBITDA
₹68.3cr−0.1% on FY25
Net profit
₹15.4cr+331.8% on FY25
EPS
₹0.63+320.0% on FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025
560562556
19.819.820.9
580581576
Expenses
342344337
16.316.321.4
−1.3−3.2−3.5
46.947.150.3
16.718.523.0
52.952.651.1
87.588.981.6
561564561
68.768.368.3
15.815.717.2
Profit
18.817.015.1
−0.2−0.20.0
18.616.815.1
3.82.92.8
3.73.310.0
7.46.312.8
4.84.81.2
16.015.43.6
11.110.62.4
−0.20.10.3
15.815.53.8
—15.43.6
Per share
₹0.65₹0.63₹0.15
₹0.65₹0.63₹0.15
Revenue detail — as filed
—4.80.0
Other comprehensive income — detail
−0.20.10.3
−0.20.10.4
−0.10.00.1
Per share — as-filed variants
₹0.65₹0.63₹0.15
₹0.65₹0.63₹0.15
Derived — gross profit (revenue − materials − purchases − Δ inventories)
203204200
36.3%36.4%36.0%
Adjusted (ex-exceptional items) — derived
18.817.015.1
−0.2−0.20.0
16.115.53.6
₹0.65₹0.64₹0.15
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

PRIMO₹21.75

Primo Chemicals Limited

· Chemicals
AnnualQuarterly₹ CrorePeersCHEMFABPLASTIBLENMANORGLORDSCHLOKRONOXJAYAGROGNDMCCHPALMcap ₹527 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations555.6561.7560.0
Other Income20.919.819.8
Total Income576.4581.5579.8
Expenses
+ Cost of Materials Consumed337.4344.3342.0
+ Purchases of Stock-in-Trade21.416.316.3
+ Changes in Inventories-3.5-3.2-1.3
+ Employee Benefit Expense50.347.146.9
+ Finance Costs23.018.516.7
+ Depreciation & Amortisation51.152.652.9
+ Other Expenses81.688.987.5
Total Expenses561.3564.5561.0
EBITDA68.368.368.7
EBIT17.215.715.8
Profit
PBT before Exceptional Items15.117.018.8
+ Exceptional Items0.0-0.2-0.2
Pretax Income15.116.818.6
+ Current Tax2.82.93.8
+ Deferred Tax10.03.33.7
Tax Expense12.86.37.4
+ Share of Associates & JVs1.24.84.8
Net Income3.615.416.0
+ Net Income — Continuing Ops2.410.611.1
+ Other Comprehensive Income0.30.1-0.2
Total Comprehensive Income3.815.515.8
Net Income to Common3.615.4—
Per Share
Basic EPS0.150.630.65
Diluted EPS0.150.630.65
Revenue Detail — as filed
+ Share of P&L — Partnership Firms / LLPs0.04.8—
Other Comprehensive Income — detail
+ Other Comprehensive Income0.30.1-0.2
+ Items NOT to be Reclassified to P&L0.40.1-0.2
+ Tax on Items NOT to be Reclassified0.10.0-0.1
Per Share — as-filed variants
Basic EPS — Continuing Operations0.150.630.65
Diluted EPS — Continuing Operations0.150.630.65
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit200.2204.3203.1
Gross Margin %36.0336.3836.26
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)15.117.018.8
− Exceptional Items (reconciliation)0.0-0.2-0.2
Net Income Adj (tax-effected)3.615.516.1
EPS Adj0.150.640.65
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.00
Paid Up Equity Capital48.548.548.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.